Raben David bought BCAX
March 4, 2026 · Form 4 insider transaction
Raben David bought 16,300 shares of Bicara Therapeutics Inc. at $3.79 per share, a transaction worth $61.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
16,300
Price
$3.79
Total value
$61.8K
InsiderRaben David
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 4, 2026
Filing dateMarch 5, 2026
Shares owned after71,586
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.